HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
G Scalia Selected Research
G Scalia Research Topics
Disease
2
Infections
12/2019 - 01/2000
2
Neoplasms (Cancer)
04/2016 - 05/2009
2
Hairy Cell Leukemia
12/2002 - 03/2000
2
Lymphoma (Lymphomas)
03/2000 - 03/2000
1
Papillomavirus Infections
12/2019
1
Prostatitis
12/2019
1
Cardiac Arrhythmias (Arrythmia)
03/2010
1
Septic Shock (Toxic Shock Syndrome)
03/2010
1
Diabetes Complications
02/2002
1
Diabetes Mellitus
02/2002
1
Type 2 Diabetes Mellitus (MODY)
02/2002
1
Edema (Dropsy)
03/2001
1
Hypertrophy
03/2001
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2000
1
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
03/2000
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2000
1
B-Cell Prolymphocytic Leukemia
03/2000
Drug/Important Bio-Agent (IBA)
2
DNA (Deoxyribonucleic Acid)
IBA
12/2019 - 01/2000
1
Antigens
IBA
04/2016
1
Brain Natriuretic Peptide (Natrecor)
FDA Link
03/2010
1
Albumins
IBA
03/2010
1
Racivir
IBA
03/2010
1
Cladribine
FDA Link
Generic
12/2002
1
Rituximab (Mabthera)
FDA Link
12/2002
1
Interferon-alpha (Interferon Alfa)
IBA
12/2002
1
Free Radicals
IBA
02/2002
1
Antioxidants
IBA
02/2002
1
Biomarkers (Surrogate Marker)
IBA
02/2002
1
Lipids
IBA
02/2002
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
02/2002
1
Sulfhydryl Compounds (Thiols)
IBA
02/2002
1
Angiotensin II
IBA
03/2001
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2001
1
CD18 Antigens
IBA
03/2000
1
CD11c Antigen
IBA
03/2000
1
fludarabine
IBA
03/2000
Therapy/Procedure
1
Transplantation
05/2009
1
Aftercare (After-Treatment)
12/2002
1
Therapeutics
02/2002
1
Drug Therapy (Chemotherapy)
03/2000
1
Salvage Therapy
03/2000